Foundation Medicine, Inc. (FMI) saw a big move last session, as the company’s shares fell by nearly 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for FMI as the stock is now up around 30% in the past one-month time frame.
The molecular information products provider has seen a flat track record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases), and the consensus for loss hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.
FMI currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Medical sector include AngioDynamics Inc. (ANGO), ABIOMED, Inc. (ABMD) and DexCom, Inc. (DXCM). While AngioDynamics sports a Zacks Rank #1 (Strong Buy), ABIOMED and DexCom carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment